GB2025398B - Gephalosporin antibiotics - Google Patents

Gephalosporin antibiotics

Info

Publication number
GB2025398B
GB2025398B GB7918488A GB7918488A GB2025398B GB 2025398 B GB2025398 B GB 2025398B GB 7918488 A GB7918488 A GB 7918488A GB 7918488 A GB7918488 A GB 7918488A GB 2025398 B GB2025398 B GB 2025398B
Authority
GB
United Kingdom
Prior art keywords
gephalosporin
antibiotics
gephalosporin antibiotics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB7918488A
Other languages
English (en)
Other versions
GB2025398A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of GB2025398A publication Critical patent/GB2025398A/en
Application granted granted Critical
Publication of GB2025398B publication Critical patent/GB2025398B/en
Priority to MY17/84A priority Critical patent/MY8400017A/xx
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB7918488A 1978-05-26 1979-05-25 Gephalosporin antibiotics Expired GB2025398B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MY17/84A MY8400017A (en) 1978-05-26 1984-12-30 Cephalosporin antibiotics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2291178 1978-05-26

Publications (2)

Publication Number Publication Date
GB2025398A GB2025398A (en) 1980-01-23
GB2025398B true GB2025398B (en) 1982-08-11

Family

ID=10187065

Family Applications (2)

Application Number Title Priority Date Filing Date
GB7918488A Expired GB2025398B (en) 1978-05-26 1979-05-25 Gephalosporin antibiotics
GB7918488A Expired GB2058791B (en) 1978-05-26 1979-05-25 Cephalosporin antibiotics

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB7918488A Expired GB2058791B (en) 1978-05-26 1979-05-25 Cephalosporin antibiotics

Country Status (10)

Country Link
JP (6) JPS54154786A (ja)
KR (2) KR830000606B1 (ja)
AT (2) AT369380B (ja)
BE (1) BE876538A (ja)
CA (1) CA1132538A (ja)
CY (1) CY1168A (ja)
GB (2) GB2025398B (ja)
HU (1) HU184631B (ja)
IT (1) IT1210588B (ja)
ZA (2) ZA807323B (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2052490B (en) * 1979-05-25 1983-09-07 Glaxo Group Ltd Intermediates for use in the preparation of cephalosporin antibiotics
ZA806977B (en) * 1979-11-19 1981-10-28 Fujisawa Pharmaceutical Co 7-acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
DE3006888A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
JPS5756486A (en) * 1980-08-11 1982-04-05 Fujisawa Pharmaceut Co Ltd Novel cephem compound or its salt, their preparation and prophylactic or remedy for microbism containing the same as active ingredient
US4336253A (en) 1981-03-11 1982-06-22 Eli Lilly And Company Cephalosporin antibiotics
DE3207840A1 (de) * 1982-03-04 1983-09-15 Hoechst Ag, 6230 Frankfurt "cephalosporinderivate und verfahren zu ihrer herstellung"
JPS5910593A (ja) 1982-06-28 1984-01-20 Bristol Mayers Kenkyusho Kk セフアロスポリン誘導体
DE3239365A1 (de) * 1982-10-23 1984-04-26 Bayer Ag, 5090 Leverkusen Neue cephalosporine und verfahren zu ihrer herstellung
DE3381408D1 (de) * 1982-12-27 1990-05-10 Lilly Co Eli Zwischenverbindungen fuer die herstellung von ceftazidin und verfahren zu ihrer herstellung.
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
GB8413152D0 (en) * 1983-06-03 1984-06-27 Ici Pharma Cephalosporin derivatives
US4855420A (en) * 1983-06-03 1989-08-08 Ici Pharma Cephalosporin derivatives
GB8406218D0 (en) * 1984-03-09 1984-04-11 Glaxo Group Ltd Process
GB8410992D0 (en) * 1984-04-30 1984-06-06 Glaxo Group Ltd Process
GB8410993D0 (en) * 1984-04-30 1984-06-06 Glaxo Group Ltd Process
GB8410991D0 (en) * 1984-04-30 1984-06-06 Glaxo Group Ltd Process
FI851934L (fi) * 1984-05-30 1985-12-01 Ici Plc Kefalosporinderivat.
CA1296012C (en) 1986-03-19 1992-02-18 Susumu Nakagawa 6,7-dihydroxy-isoquinoline derivatives
KR0164458B1 (ko) * 1995-04-04 1999-01-15 김은영 암모니오세팔로스포린 계열 항생제 및 그의 제조방법
US5872249A (en) * 1995-09-01 1999-02-16 Korea Institute Of Science And Technology 3-ammoniopropenyl cephalosporin compounds as antibacterial agents and process for preparing the same
JPH09110877A (ja) 1995-10-17 1997-04-28 Katayama Seiyakushiyo:Kk セフェム化合物、その製造法及びそれを含有する抗菌剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597717B2 (ja) * 1976-09-08 1984-02-20 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法

Also Published As

Publication number Publication date
CY1168A (en) 1983-06-10
JPS6127990A (ja) 1986-02-07
KR830000606B1 (ko) 1983-03-17
JPS6127989A (ja) 1986-02-07
AT369380B (de) 1982-12-27
JPS55149289A (en) 1980-11-20
ZA792581B (en) 1981-01-28
JPS6322093A (ja) 1988-01-29
AT369381B (de) 1982-12-27
IT8149648A0 (it) 1981-11-06
JPH0257069B2 (ja) 1990-12-03
JPS6354689B2 (ja) 1988-10-28
KR830000835B1 (ko) 1983-04-20
GB2058791B (en) 1982-11-24
ZA807323B (en) 1981-02-25
ATA173981A (de) 1982-05-15
JPS625916B2 (ja) 1987-02-07
CA1132538A (en) 1982-09-28
GB2025398A (en) 1980-01-23
JPS54154786A (en) 1979-12-06
GB2058791A (en) 1981-04-15
IT1210588B (it) 1989-09-14
BE876538A (fr) 1979-11-26
ATA173881A (de) 1982-05-15
JPH0257554B2 (ja) 1990-12-05
HU184631B (en) 1984-09-28
JPH0257073B2 (ja) 1990-12-03
JPS6127921A (ja) 1986-02-07

Similar Documents

Publication Publication Date Title
PH16961A (en) Cephalosporin antibiotics
GB2025398B (en) Gephalosporin antibiotics
IL57398A0 (en) Cepahlosporin antibiotics
AU531616B2 (en) A-21978 antibiotics
GB2041360B (en) Antibiotic
ZA806082B (en) Cephalosphorin antibiotics
GB2032913B (en) Antibiotic sb-72310
IL58717A0 (en) Cephalosporin antibiotics
GB2016005B (en) Anthracycline antibiotics
GB2017705B (en) B-lactam antibiotics
AU531801B2 (en) Chphalosporin antibiotics
GB2021582B (en) Antibiotics
AU539983B2 (en) 2-penem antibiotics
GB2040921B (en) Cephalosporin antibiotics
ZA796130B (en) Cephalosporin antibiotics
ZA792582B (en) Cephalosporin antibiotics
GB2021558B (en) Antibiotic substance mycoplanecin
GB2036738B (en) Cephalosporin antibiotics
GB2027691B (en) Cephalosporin antibiotics
GB2028806B (en) Streptomycin antibiotics
GB2055794B (en) Planothiocin antibiotics
GB2027692B (en) Cephalosporin antibiotics
ZA792584B (en) Cephalosporin antibiotics
GB2024808B (en) Cephalosporin antibiotics
IE790792L (en) Synergistic antibiotics

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 19990524